Christopher L. Amling

DEFINING PROSTATE SPECIFIC ANTIGEN PROGRESSION AFTER RADICAL PROSTATECTOMY: WHAT IS THE MOST APPROPRIATE CUT POINT?

Christopher L. Amling, Horst Zincke · The Journal of Urology · 2001 · 409 citations

Medicine, Oncology, Urology +13

Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality

Robert T. Dess, Holly Hartman, Brandon A. Mahal et al. · JAMA Oncology · 2019 · 409 citations · Full text

Medicine, Oncology, Urology +17

Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group

Stephen J. Freedland, William J. Aronson, Christopher J. Kane et al. · Journal of Clinical Oncology · 2003 · 387 citations

Medicine, Oncology, Surgery +12

Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy

Christopher L. Amling, Robert H. Riffenburgh, Leon Sun et al. · Journal of Clinical Oncology · 2003 · 385 citations · Full text

Medicine, Oncology, Urology +17

LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARS

Christopher L. Amling, Michael L. Blute, Erik J. Bergstralh et al. · The Journal of Urology · 2000 · 359 citations

Medicine, Surgery, Urology +8